LaunchHealthOctober 20, 2026

SimBioSys wins FDA clearance for AI breast cancer recurrence risk tool

Read original source →news.google.com

SimBioSys received FDA clearance for an AI tool that predicts breast cancer recurrence risk, per MobiHealthNews. No launch date, pricing, or clinical validation figures were disclosed in the report.

1 source

More stories today

Open the live feed